Characterization of the Overlap Syndrome of Primary Biliary Cirrhosis (Pbc) and Autoimmune Hepatitis: Evidence for It Being A Hepatitic Form of Pbc in Genetically Susceptible Individuals
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Some patients with autoimmune liver disease present with a clinical and/or histological picture showing characteristic findings of both autoimmune hepatitis (AIH) and primary biliary cirrhosis (PBC). Various names, mostly overlap syndrome, have been used to describe these cases, which have thus far not been more closely characterized. The aim of this study was the comparison of 20 patients with overlapping features to representative patients considered suffering from typical AIH or typical PBC (20 patients in each group). We found these patients to indeed show a very mixed picture of both conditions biochemically, serologically, and histologically. However, closer analysis suggested that all of these patients were primarily suffering from PBC as all of them had at least either bile duct destruction on histology or anti–M2 positive antimitochondrial antibodies (AMA). We suggest that these PBC patients because of their genetic susceptibility, evidenced by the AIH–characteristic histocompatibility leukocyte antigen (HLA) type B8, DR3, or DR4, developed a more hepatitic picture. Response to immunosuppressive therapy was excellent. We propose that the name “overlap syndrome” be abandoned for “PBC, hepatitic form.” These observations not only have pathophysiological implications, but also suggest that therapy of PBC should be guided by the degree of biochemical and histological hepatic involvement
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This combined treatment regime has been used in patients with PBC and features of AIH with high response rates [160,161,175,180].”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [180]
In the citing paper
“These criteria have been met in 1% to 14.2% of PBC patients, with higher rates found in Hispanic PBC patients.(128)(129)(130)(131)(132)(133)”
From Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases (2019) · cites this paper as [128]
Citations
Cites
Chazouillères, O., Wendum, D., Serfaty, L., Montembault, S., Rosmorduc, O., & Poupon, R. (1998) · Hepatology · doi:10.1002/hep.510280203 · Cited by 746
Bach, N., Thung, S. N., & Schaffner, F. (1992) · Hepatology · doi:10.1002/hep.1840150403 · Cited by 500
Ursodiol for the Long-Term Treatment of Primary Biliary Cirrhosis
Poupon, R. E., Poupon, R., & Balkau, B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405123301903 · Cited by 497
Manns, M., Kyriatsoulis, A., Gerken, G., Staritz, M., Meyer, K. H., & Büschenfelde, Z. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92024-1 · Cited by 424
Self-citationFrequency and nature of the variant syndromes of autoimmune liver disease
Czaja, A. J. (1998) · Hepatology · doi:10.1002/hep.510280210 · Cited by 343
Michieletti, P., Wanless, I. R., Katz, A., Scheuer, P. J., Yeaman, S. J., Bassendine, M. F., Palmer, J. M., & Heathcote, E. J. (1994) · Gut · doi:10.1136/gut.35.2.260 · Cited by 236
Autoimmune cholangiopathy: Part of the spectrum of autoimmune chronic active hepatitis
Ben-Ari, Z., Dhillon, A. P., & Sherlock, S. (1993) · Hepatology · doi:10.1002/hep.1840180103 · Cited by 218
Krawitt, E. L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604043341406 · Cited by 206
Van de Water, J., Cooper, A., Surh, C. D., Coppel, R., Danner, D., Ansari, A., Dickson, R., & Gershwin, M. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198905253202104 · Cited by 201
Goodman, Z. D., McNally, P. R., Davis, D. R., & Ishak, K. G. (1995) · Digestive Diseases and Sciences · doi:10.1007/bf02065530 · Cited by 178
Research works printed but not linked: 1
- Bianchi, 1994, Pathology of the Liver, 349
Cited by
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.009 · Cited by 1,729
“However, adjunction of immunosuppressive therapy was required in most patients of other cohorts to obtain a complete biochemical response [57,58].”
BackgroundHirschfield, G. M., Beuers, U., Corpechot, C., Invernizzi, P., Jones, D., Marzioni, M., & Schramm, C. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.022 · Cited by 1,480
“This combined treatment regime has been used in patients with PBC and features of AIH with high response rates [160,161,175,180].”
Diagnosis and management of autoimmune hepatitis
Manns, M. P., Czaja, A. J., Gorham, J. D., Krawitt, E. L., Mieli-Vergani, G., Vergani, D., & Vierling, J. M. (2010) · Hepatology · doi:10.1002/hep.23584 · Cited by 1,442
EASL Clinical Practice Guidelines: autoimmune hepatitis
(2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.06.030 · Cited by 1,245
(2011) · Encyclopedia of Cancer · doi:10.1007/978-3-642-16483-5_4730 · Cited by 1,240
Metadata
- Authors
- Lohse, A. W., zum Büschenfelde, K.-H. M., Franz, B., Kanzler, S., Gerken, G., & Dienes, H.-P.
- Affiliations
- Johannes Gutenberg University Mainz (DE)
- University of Cologne (DE)
- Corresponding author
- Lohse, Ansgar W.
- Venue
- Hepatology
- Published
- 1999-04
- Volume
- 29
- Issue
- 4
- Pages
- 1078-1084
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2171662843
- Semantic Scholar
- aede3440eeab4134d81165c39316c389536598b6
- Cited by
- 278
- References
- 32
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 6 · 2022: 5 · 2021: 6 · 2020: 8 · 2019: 4 · 2018: 8 · 2017: 11 · 2016: 5 · 2015: 3 · 2014: 12 · 2013: 11 · 2012: 13
- FWCI
- 8.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 5997 d)
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft, Bonn ((SFB 311))
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Health Sciences › Medicine › Rheumatology › IgG4-Related and Inflammatory Diseases
- Keywords
- primary biliary cirrhosis, autoimmune hepatitis, overlap syndrome, antimitochondrial antibodies, HLA-DR3, HLA-DR4, HLA-B8, genetic susceptibility, bile duct destruction, immunosuppressive therapy
- MeSH terms
- Adolescent, Adult, Aged, Autoantibodies, Biopsy, Female, Follow-Up Studies, Histocompatibility Testing, Humans, Immunosuppressive Agents, Liver Cirrhosis, Biliary, Male, Middle Aged, Serologic Tests, Syndrome, Hepatitis, Autoimmune, Genetic Predisposition to Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Characterization of the Overlap Syndrome of Primary Biliary Cirrhosis (Pbc) and Autoimmune Hepatitis: Evidence for It Being A Hepatitic Form of Pbc in Genetically Susceptible Individuals. https://app.cochat.ai/papers/10.1002/hep.510290409
- The paper
- Lohse, A. W., zum Büschenfelde, K.-H. M., Franz, B., Kanzler, S., Gerken, G., & Dienes, H.-P. (1999). Characterization of the Overlap Syndrome of Primary Biliary Cirrhosis (Pbc) and Autoimmune Hepatitis: Evidence for It Being A Hepatitic Form of Pbc in Genetically Susceptible Individuals. Hepatology. https://doi.org/10.1002/hep.510290409
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.